Stromatec, Inc. develops tools for clinicians to diagnose and treat problems in connective tissues that provide support and structure throughout the body. It offers tools to help solve problems associated with musculoskeletal connective tissues, such as chronic pain, scarring, or impaired mobility. The company develops Acusensor that provides the technology to measure, document, and analyze the needling component of treatment; StromaTorque, which uses needle torque measurements to determine the cause for chronic pain; and StromaGlide that uses needle stimulation and ultrasound elastography to determine cause for chronic pain. Its technologies include biomarkers, diagnostics, and treatments for users, such as research scientists, physicians, and acupuncture students. The company was founded in 2003 and is based in Burlington, Vermont.
Stromatec seeks to help people move freely, without pain, by developing technologies that diagnose and treat connective tissue problems.
Key Executives for Stromatec, Inc.